MedTrace Logo

Study of Laser Treatment of Melasma

NCT01335581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2022-01-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the RevLite laser in the treatment of refractory mixed type melasma.

Conditions

  • Refractory Mixed Type Melasma

Interventions

DEVICE

Q-Switched Nd:YAG Laser (RevLite)

Laser treatment added to a microdermabrasion and topical lightening agent regimen

DRUG

Retin-A and microdermabrasion

Microdermabrasion and topical lightening agent regimen

Sponsors & Collaborators

  • ConBio, a Cynosure Company

    lead INDUSTRY

Principal Investigators

  • Arielle Kauvar, MD · New York Laser and Skin Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01335581 on ClinicalTrials.gov